Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Phase 3

Recruiting

• Conditions: Brain Injuries
• Interventions: Drug: Nucleo CMP Forte

• Registration Number: NCT04499755
• Lead Sponsor: Sherief Abd-Elsalam

Brief Summary

Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Detailed Description

The study aims to study the Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Study Timeline

• Study Start: 2020-06-01
• Status Verified: 2020-08
• Study First Submitted: 2020-08-01
• Study First Submitted QC: 2020-08-01
• Last Update Submitted: 2020-08-01
• Study First Posted: 2020-08-05
• Last Update Posted: 2020-08-05
• Primary Completion: 2030-12-01
• Study Completion: 2030-12-10

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Children with traumatic brain injury: Moderate and Severe.

Read More

Exclusion Criteria

• Underlying CNS disorders,

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Nucleo CMP forte	Nucleo CMP Forte	Nucleo CMP forte twice daily for 6 weeks with supportive treatment.

Primary Outcome Measures

Name	Time	Method
Number of patients with improved glasgow coma score	2 months	The number of patients with improved glasgow coma score

Trial Locations

Locations (1)

Sherief Abd-Elsalam; 🇪🇬 Tanta, Egypt